ArticleInternational journal of molecular sciences2026
TNFRSF10B Implicated in Osteoarthritis Protection via the Alpha-Tocopherol-to-Sulfate Ratio: A Multiomics and Mendelian Randomization Study.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Osteoarthritis (OA) is a chronic inflammatory and degenerative joint disease that commonly affects the aging population. This study was designed to decipher gene-metabolite regulatory networks driving OA progression via combined computational prediction and experimental validation. Differential gene expression analysis, weighted gene coexpression network analysis, and machine learning algorithms were integrated to screen for key regulatory genes. To infer causal associations between these candidates and OA susceptibility, we performed Mendelian randomization (MR) using cis-expression quantitative trait loci (cis-eQTL) as genetic instruments and identified significant associations between TNFRSF10B and OA. In parallel, single-nucleus RNA sequencing (snRNA-seq) was used to map the cell-type-specific expression profile of TNFRSF10B, and its expression was validated in human knee synovial tissues. The protective effect of TNFRSF10B on OA was statistically mediated in part by the alpha-tocopherol-to-sulfate ratio, as inferred from Mendelian randomization analysis, with the indirect effect accounting for 16.85% (95% CI: 2.96-30.74%) of the total protective effect. snRNA-seq data revealed that TNFRSF10B was widely expressed across synovial cell populations but reduced in OA samples. Collectively, this study identified TNFRSF10B as a candidate protective factor in OA, supported by genetic evidence from MR analysis and reduced expression in OA synovial tissues, offering statistical evidence for gene-metabolite interplay in OA pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.